SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

03 Dec 2018 Evaluate

Sun Pharmaceutical Industries has informed about submission of Press Release relating to ‘Investor Update’ call on December 03, 2018.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1832.40 11.65 (0.64%)
06-May-2026 10:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1832.40
Dr. Reddys Lab 1284.60
Cipla 1340.95
Zydus Lifesciences 926.95
Lupin 2391.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×